TY  - JOUR
AU  - Puig, Lluís
AU  - Fernández-Freire, Lourdes Rodríguez
AU  - Burgos-Pol, Ramón
AU  - Gomez, Ismael
AU  - Peral, Carmen
AU  - Gomez, Susana
AU  - Rebollo Laserna, Francisco José
PY  - 2019
DO  - 10.1007/s13555-019-0301-6
SN  - 2193-8210
UR  - https://hdl.handle.net/10668/27416
T2  - Dermatology and therapy
AB  - Etanercept (ETN), a highly effective biological agent for the treatment of psoriasis (PSO) and psoriatic arthritis (PsA), is widely used in Spain. However, evidence of its economic impact is limited, indicating the need for a systematic review of the...
LA  - en
KW  - Economic evaluations
KW  - Etanercept
KW  - Psoriasis
KW  - Psoriatic arthritis
KW  - Spain
KW  - Systematic review
TI  - Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review.
TY  - research article
VL  - 9
ER  -